Thursday, November 26, 2009

Novartis opens first large-scale cell-culture influenza vaccine manufacturing facility in US

Novartis officially inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a partnership between Novartis and the US Department of Health and Human Services (HHS).

The details can be read here.

No comments: